CD8a Monoclonal Antibody (53-6.7), Super Bright 436, eBioscience and 1 more item

The University of Virginia awarded a contract to Life Technologies Corporation on July 16, 2026, for the procurement of laboratory reagents and monoclonal antibodies. The contract, identified as A207_PO-0458919, represents a cumulative value of $708.00 and includes two line items for delivery to Jessica Fay Johns. The supplies consist of specialized immunological research materials: one unit of CD8a Monoclonal Antibody (53-6.7), Super Bright 436, manufactured by eBioscience, priced at $298.50, and one unit of FOXP3 Monoclonal Antibody (FJK-16s), PE, also manufactured by eBioscience, priced at $410.28.

Life Technologies Corporation fulfilled this requirement as the prime contractor for the Commonwealth of Virginia. The contract deliverables are consistent with the University of Virginia's research and laboratory operations, with all items designated for delivery to the identified recipient. The relatively modest contract value and specific nature of the monoclonal antibodies indicate this procurement supports scientific research activities requiring specialized flow cytometry or immunological analysis capabilities. No information regarding contract duration or performance period is available in the provided documentation.